This article reviews the current state of the dermal market and offers a macro environmental view, from both a consumer and regulatory perspective. It also discusses the benefits of Airless technology and the connected opportunities available to enhance patient adherence and support a vision of digital health for pharmaceutical companies, healthcare providers and consumers in the dermal space.
Airless Drug Delivery: Widely Accepted, Accessible and Available
Airless technology, although widely recognised for its clear benefits around safety, reliability, convenience and patient experience, has not yet witnessed the universal adoption one would have expected.
Subscribe to Email Updates
Submit your email address below and stay up to date with the latest industry insights.
*Required. For details about how your email address will be used, read our General Terms and Conditions of Use, Privacy and Cookies Policy.